The pandemic provided a reason to the stock market to be excited about the pharma sector that had been facing lacklustre prospects amid challenges in the US business, USFDA compliance issues, pricing pressure, big-bang acquisitions not working out on expected lines and modest growth in the domestic market.
10 IPOs more than doubled investor money on listing day in last 5 yrs
Here’s a look at the initial public offers that have seen the best performance on the listing day in the last ten years. (Source: ET
December 11, 2023